News | November 06, 2023
Poly Medicure posts consolidated Q2 FY24 PAT at Rs. 62.18 Cr
Poly Medicure has reported total income of Rs. 351.38 crores during the period ended September 30, 2023
Poly Medicure has reported total income of Rs. 351.38 crores during the period ended September 30, 2023
The company has reported total income of Rs. 107.22 crores during the period ended September 30, 2023
The newly developed adhesive is available in two different grades. Loctite WT 3001 and Loctite WT 3003 h
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
Subscribe To Our Newsletter & Stay Updated
